Использование в комплексном лечении криосупернатантной фракции плазмы для коррекции тромбогеморрагического синдрома у септических больных
Published in Актуальные проблемы медицины • Jun 30, 2025
NobleIDNI1P56W34R11S84
Authors:,,
Е. А. Цеймах
V. Yu. Zinchenko
A. В. Калашников
Abstract
Purulent-inflammatory diseases are widespread and account for 1/3 of all surgical pathology. A severe life-threatening condition is the development of sepsis, with a mortality rate of up to 43 %. The aim of the study was to compare the dynamics of the course of thrombohemorrhagic syndrome with the u...